Cargando…

Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol

BACKGROUND: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrou...

Descripción completa

Detalles Bibliográficos
Autores principales: Jingu, Akiko, Fukuda, Junya, Taketomi-Takahashi, Ayako, Tsushima, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195268/
https://www.ncbi.nlm.nih.gov/pubmed/25287952
http://dx.doi.org/10.1186/1471-2342-14-34
_version_ 1782339282947538944
author Jingu, Akiko
Fukuda, Junya
Taketomi-Takahashi, Ayako
Tsushima, Yoshito
author_facet Jingu, Akiko
Fukuda, Junya
Taketomi-Takahashi, Ayako
Tsushima, Yoshito
author_sort Jingu, Akiko
collection PubMed
description BACKGROUND: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrough reaction; BTR). The purpose of this study was to assess the frequency, type and severity of BTR when following an oral steroid premedication protocol. METHODS: All iodinated and gadolinium contrast-enhanced radiologic examinations between August 2011 and February 2013 for which the premedication protocol was applied in our institution were assessed for BTRs. RESULTS: The protocol was applied to a total of 252 examinations (153 patients, ages 15–87 years; 63 males, 90 females). Of these, 152 were for prior acute adverse reactions to contrast media, 85 were for a history of bronchial asthma, and 15 were for other reasons. There were 198 contrast enhanced CTs and 54 contrast enhanced MRIs. There were nine BTR (4.5%) for iodinated contrast media, and only one BTR (1.9%) for gadolinium contrast media: eight were mild and one was moderate. No patient who had a mild index reaction (IR) had a severe BTR. CONCLUSION: Incidence of BTRs when following the premedication protocol was low. This study by no means proves the efficacy of premedication, but provides some support for following a premedication protocol to improve safety of contrast-enhanced examinations when prior adverse reactions are mild, or when there is a history of asthma.
format Online
Article
Text
id pubmed-4195268
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41952682014-10-14 Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol Jingu, Akiko Fukuda, Junya Taketomi-Takahashi, Ayako Tsushima, Yoshito BMC Med Imaging Research Article BACKGROUND: Adverse reactions to iodinated and gadolinium contrast media are an important clinical issue. Although some guidelines have proposed oral steroid premedication protocols to prevent adverse reactions, some patients may have reactions to contrast media in spite of premedication (breakthrough reaction; BTR). The purpose of this study was to assess the frequency, type and severity of BTR when following an oral steroid premedication protocol. METHODS: All iodinated and gadolinium contrast-enhanced radiologic examinations between August 2011 and February 2013 for which the premedication protocol was applied in our institution were assessed for BTRs. RESULTS: The protocol was applied to a total of 252 examinations (153 patients, ages 15–87 years; 63 males, 90 females). Of these, 152 were for prior acute adverse reactions to contrast media, 85 were for a history of bronchial asthma, and 15 were for other reasons. There were 198 contrast enhanced CTs and 54 contrast enhanced MRIs. There were nine BTR (4.5%) for iodinated contrast media, and only one BTR (1.9%) for gadolinium contrast media: eight were mild and one was moderate. No patient who had a mild index reaction (IR) had a severe BTR. CONCLUSION: Incidence of BTRs when following the premedication protocol was low. This study by no means proves the efficacy of premedication, but provides some support for following a premedication protocol to improve safety of contrast-enhanced examinations when prior adverse reactions are mild, or when there is a history of asthma. BioMed Central 2014-10-06 /pmc/articles/PMC4195268/ /pubmed/25287952 http://dx.doi.org/10.1186/1471-2342-14-34 Text en Copyright © 2014 Jingu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Jingu, Akiko
Fukuda, Junya
Taketomi-Takahashi, Ayako
Tsushima, Yoshito
Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
title Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
title_full Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
title_fullStr Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
title_full_unstemmed Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
title_short Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
title_sort breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195268/
https://www.ncbi.nlm.nih.gov/pubmed/25287952
http://dx.doi.org/10.1186/1471-2342-14-34
work_keys_str_mv AT jinguakiko breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol
AT fukudajunya breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol
AT taketomitakahashiayako breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol
AT tsushimayoshito breakthroughreactionsofiodinatedandgadoliniumcontrastmediaafteroralsteroidpremedicationprotocol